Onco Wiki / Maladie

Tumeur des cellules germinales testiculaires (TCG)

Vue déterministe de l'entité source de la LJAM. L'autorité clinique demeure avec les ID de la source cités et l'état d'approbation de l ́examinateur.

IDDIS-TESTICULAR-GCT
TypeMaladie
Alias
Tumeur à cellules germinales (TCG)Tumeur des cellules germinales non séminomateuses (TCNNG)SéminomeCancer testiculaireTumeur des cellules germinatives testiculairesTémoignages mixtes GCTГерміногенна пухлина яєчка
Étatreviewed 2026-05-04 | pending_clinical_signoff
MaladiesAucune déclaration
SourcesAucune déclaration

Informational support. All recommendations must be verified by a qualified oncologist. Engineering checks are not clinical validation or treatment approval.

Source YAML

icd_o_3_morphology9061/3
icd_o_3_topography["C62.0", "C62.1", "C62.9"]
icd_10C62.9
who_classificationWHO Urinary and Male Genital Tumours 5th ed (2022): Germ cell tumours

Capacités

Notes

Testicular GCT is the most common solid tumor in men aged 15-35 and one of the most curable cancers even at metastatic stage (BEP-based chemotherapy cures ~80-92% of metastatic good/intermediate-risk GCT; ~50% poor-risk). Early diagnosis via self-examination + ultrasound is critical. All staging workup requires serum AFP, beta-hCG, LDH at diagnosis and post-orchiectomy to determine marker trajectory. RPLND (retroperitoneal lymph node dissection) is used for: residual masses after chemotherapy (seminoma → PET-guided; NSGCT → surgery for >1cm residual), pathologic stage I NSGCT surveillance-alternative.

Utilisé par

Algorithmes

Indication

Questionnaires

Protocole thérapeutique

Sources